New US national security rules are set to disproportionately hit Chinese investments in sensitive industries such as biotechnology and nanotechnology.
Over the past three years, Chinese venture capitalists have become big investors in US start-ups specialising in early-stage technologies.
While overall Chinese investment in the US has dramatically decreased because of scrutiny from regulators, small non-controlling investments have not faced national security reviews and have grown at a record pace.
您已閱讀14%（502字），剩餘86%（3153字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。